These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 2442262

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of "regulatory" idiotope-specific T cell clones to a monoclonal anti-idiotypic antibody mimicking a tumor-associated antigen (TAA).
    Saeki Y, Chen JJ, Shi LF, Raychaudhuri S, Köhler H.
    J Immunol; 1989 Feb 01; 142(3):1046-52. PubMed ID: 2783599
    [Abstract] [Full Text] [Related]

  • 11. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP, Vitetta ES, Forman J.
    J Immunol; 1986 Aug 15; 137(4):1371-5. PubMed ID: 2426362
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help.
    Savelyeva N, King CA, Vitetta ES, Stevenson FK.
    Proc Natl Acad Sci U S A; 2005 Aug 02; 102(31):10987-92. PubMed ID: 16037207
    [Abstract] [Full Text] [Related]

  • 13. Idiotype-specific T helper clones recognize a variable H chain determinant.
    Saeki Y, Chen JJ, Shi LF, Okuda Y, Köhler H.
    J Immunol; 1990 Mar 01; 144(5):1625-8. PubMed ID: 1689751
    [Abstract] [Full Text] [Related]

  • 14. Idiotype matching: correlation of expression of protective idiotype in sera with survival of tumor mice.
    Chen JJ, Saeki Y, Köhler H.
    J Immunol; 1990 Jan 15; 144(2):759-64. PubMed ID: 2295810
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a hybridoma-derived T cell factor that promotes the production of antibodies bearing a dominant cross-reactive idiotype(s).
    Wardzala AM, Bowen MB, Jendrisak GS, Bellone CJ.
    J Mol Cell Immunol; 1986 Jan 15; 2(5):243-53. PubMed ID: 2978231
    [Abstract] [Full Text] [Related]

  • 16. Sporadic idiotypic cross-reactivities between antibodies and T helper cells: one example of aleatory expression of T cell idiotypes.
    Martinez C, Coutinho A, Bandeira A, de la Hera A, Toribio M, Marcos MA, Pereira P.
    J Mol Cell Immunol; 1987 Jan 15; 3(1):21-8. PubMed ID: 2978237
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of idiotype suppression. V. Anti-idiotype antibody inhibits early B cell triggering induced by antigen.
    Kim BS, Massey PB, Hui KM.
    J Immunol; 1983 Feb 15; 130(2):596-601. PubMed ID: 6600243
    [Abstract] [Full Text] [Related]

  • 18. Recognition of idiotypes in lymphocyte interactions. I. Idiotypic selectivity in the cooperation between T and B lymphocytes.
    Hetzelberger D, Eichmann K.
    Eur J Immunol; 1978 Dec 15; 8(12):846-52. PubMed ID: 83234
    [Abstract] [Full Text] [Related]

  • 19. Anti-idiotype antibodies: an alternative approach to tumor immunotherapy.
    Raychaudhuri S.
    Indian J Exp Biol; 1989 Aug 15; 27(8):671-80. PubMed ID: 2699310
    [Abstract] [Full Text] [Related]

  • 20. Tumor idiotype vaccines. VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2.
    Raychaudhuri S, Kang CY, Kaveri SV, Kieber-Emmons T, Köhler H.
    J Immunol; 1990 Jul 15; 145(2):760-7. PubMed ID: 2164069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.